CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
November 7, 2019 6:55 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $71.00 price target on CVS Health (NYSE: CVS) following the company's 3Q earnings report. CVS reported 3Q:19 EPS of $1.84, above consensus of $1.76. Adjusted operating profit was $3.947bn versus consensus at $3.89bn.
The tone of... More
CVS Health (CVS) Trades to High, Up 5% Following Results Earllier
November 6, 2019 10:01 AM ESTCVS Health (NYSE: CVS) Trades to High, Up 5% Following Results Earllier
... MoreCVS Health (CVS) Tops Q3 EPS by 7c, Raises FY EPS Guidance
November 6, 2019 6:32 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.84, $0.07 better than the analyst estimate of $1.77. Revenue for the quarter came in at $64.8 billion versus the consensus estimate of $63.01 billion.
GUIDANCE:
CVS Health sees FY2019 EPS of $6.97-$7.05, versus the consensus of... More
